Elicio Therapeutics (ELTX) Change in Cash (2020 - 2026)
Elicio Therapeutics' (ELTX) quarterly Change in Cash came in at -$3.6 million in Q1 2026, down 1605.42% YoY from $240000.0 in Q1 2025, and down 76.59% on a QoQ basis from -$2.0 million in Q4 2025.
Elicio Therapeutics (ELTX) Change in Cash (2020 - 2026) Analysis & Trends
Elicio Therapeutics (ELTX) has 7 years of Change in Cash data on file, last reported at -$3.6 million in Q1 2026.
- Quarterly Change in Cash fell 1605.42% year-over-year to -$3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.1 million (down 162.49% YoY) and the FY2025 annual result came in at -$225000.0, down 104.33% from the prior year.
- Change in Cash slipped to -$3.6 million in Q1 2026, from -$2.0 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $23.5 million in Q3 2024 to a low of -$15.8 million in Q1 2022.
- A 5-year average of $329941.2 and a median of -$1.1 million in 2024 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2024 — Change in Cash surged 555.03% — and 2026, when it plunged 1605.42%.
- Tracing ELTX's Change in Cash over 5 years: stood at $3.8 million in 2022, then tumbled by 176.06% to -$2.9 million in 2023, then sank by 194.92% to -$8.5 million in 2024, then jumped by 76.03% to -$2.0 million in 2025, then sank by 76.59% to -$3.6 million in 2026.
- The last three Change in Cash figures came in at -$3.6 million (Q1 2026), -$2.0 million (Q4 2025), and -$1.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Elicio Therapeutics | 58.41 Mn | 34.91 Mn | - | 8.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.34 Mn |
| Mar 31, 2026 | -3.61 Mn |
| Dec 31, 2025 | -2.05 Mn |
| Sep 30, 2025 | -1.48 Mn |
| Jun 30, 2025 | 3.06 Mn |
| Mar 31, 2025 | 240,000.00 |
| Dec 31, 2024 | -8.54 Mn |
| Sep 30, 2024 | 23.52 Mn |
| Jun 30, 2024 | -8.70 Mn |
| Mar 31, 2024 | -1.10 Mn |
| Dec 31, 2023 | -2.89 Mn |
| Sep 30, 2023 | -5.17 Mn |
| Jun 30, 2023 | 12.07 Mn |
| Mar 31, 2023 | 1.88 Mn |
| Dec 31, 2022 | 3.81 Mn |
| Sep 30, 2022 | 3.39 Mn |
| Jun 30, 2022 | 6.93 Mn |
| Mar 31, 2022 | -15.75 Mn |
| Dec 31, 2021 | -13.98 Mn |
| Sep 30, 2021 | -14.58 Mn |